Home
Home

biotech

Amicus Therapeutics: One Biotech Firm Making Considerable Strides In Terms Of Pompe Disease

Amicus Therapeutics: One Biotech Firm Making Considerable Strides In Terms Of Pompe Disease
Seeking Alpha

A Leading Biotechnology Company Offering Explosive Growth

A Leading Biotechnology Company Offering Explosive Growth
The Motley Fool

2 Biotech Companies Making Considerable Strides When It Comes To Pain Management

2 Biotech Companies Making Considerable Strides When It Comes To Pain Management
Seeking Alpha

2 Biotech Short-Squeeze Candidates For The New Year

2 Biotech Short-Squeeze Candidates For The New Year
Seeking Alpha

Expect bold moves in the biopharma industry in 2013

Expect bold moves in the biopharma industry in 2013
Fierce Biotech

Unleashing Biotech Innovation With The Currency of Entrepreneurship

Unleashing Biotech Innovation With The Currency of Entrepreneurship
Forbes
Submitted by moderatorj on Mon, 11/19/2012 - 13:23

Biotech Industry Experiencing More FDA New Drug Approvals in 2012

Biotech Industry Experiencing More FDA New Drug Approvals in 2012
Yahoo/MarketWire\

Buyout Buzz: The most frequently cited takeover targets in biotech

Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech

Study: Amazing early-stage R&D results rarely hold up in big trials

Study: Amazing early-stage R&D results rarely hold up in big trials
Fierce Biotech

Q3 biotech venture investing makes a boisterous leap

Q3 biotech venture investing makes a boisterous leap
Fierce Biotech